// App-Quantinova.ai

499 2014 ATVB : Development of a Novel Antithrombotic Therapy Targeting Platelet GPIb?: Assessment of Anfibatide In Vitro and in Phase I Clinical Trial

Researchers

Presenter

  • Adili Reheman

Principal Investigators

  • Jie Shen

  • Hui Zhou

  • Yiming Wang

  • Alexandra H Marshall

  • Xi Lei

  • Alessandro Zarpellon

  • Karen Vanhoorelbeke

  • Zaverio Ruggeri

  • Heyu Ni

  • Xiangrong Dai

  • Zhongqiang Yang

  • Fang Qian

  • Guohui Zhang

  • Zhengyu Xu

  • Jing Liu

  • Chaofan Liang

  • Yanan Zhao

Medical Centers

  • Lees Pharmaceutical Holdings Ltd., Hefei, China

  • Zhaoke Pharmaceutical Co Ltd, Hefei, China

  • Lab for Thrombosis Res, Kortrijk, Belgium

  • St. Michael's Hosp, Toronto, ON, Canada

  • The Scripps Res Inst, La Jolla, CA

  • School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui, China

  • Gejishan Hospital of Wannan Medical College, Wuhu, China

Locations

  • United States

  • Canada

  • China

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Atherothrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Anfibatide

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved